CORRESPONDENCE / EDITORIAL ONLY
Reach the editors of the record.
For corrections, citation queries, and editorial correspondence about the CJC-1295 dossier.
Editorial correspondence
This is the contact surface for Safe CJC-1295, an independent editorial dossier on the published CJC-1295 research record. Use the form for corrections, citation queries, or questions about how a finding is summarized. If you believe a study is mischaracterized or a citation is wrong, send the study and we will check it against the page.
We respond to editorial correspondence only. We are not a clinic and not a vendor: we do not provide medical advice, we do not sell or supply any compound, and we cannot recommend doses, sources, or treatment. Inquiries about purchasing, prescribing, or administering CJC-1295 cannot be answered here, because the site does none of those things [8].
What this form is not for
Please do not use this form to request medical guidance, a prescription, a supplier, or a dosing protocol. CJC-1295 is an unapproved research chemical with no validated human use [8], and we have no clinical staff to advise on it. Questions of that kind are outside what an editorial publisher can or should answer.
For the substance of the record, the pages answer most questions directly: the safety reading, the DAC vs no-DAC distinction, the doses used in the studies, and the full reference list with every source.